|
|
||||||||
Department of Pharmacology and Pittsburgh Institute for Neurodegenerative Diseases, University of Pittsburgh School of Medicine, Pittsburgh, PA 15261

The fruit fly, Drosophila melanogaster, is a powerful model genetic organism that has been used since the turn of the previous century in the study of complex biological problems. In the last decade, numerous researchers have focused their attention on understanding neurodegenerative diseases by utilizing this model system. Numerous Drosophila mutants have been isolated that profoundly affect neural viability and integrity of the nervous system with age. Additionally, many transgenic strains have been developed as models of human disease conditions. We review the existing Drosophila neurodegenerative mutants and transgenic disease models, and discuss the role of the fruit fly in therapeutic development for neurodegenerative diseases.
This article has been cited by other articles:
![]() |
S. E. Phillips, E. A. Woodruff III, P. Liang, M. Patten, and K. Broadie Neuronal Loss of Drosophila NPC1a Causes Cholesterol Aggregation and Age-Progressive Neurodegeneration J. Neurosci., June 25, 2008; 28(26): 6569 - 6582. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Fergestad, L. Olson, K. P. Patel, R. Miller, M. J. Palladino, and B. Ganetzky Neuropathology in Drosophila Mutants With Increased Seizure Susceptibility Genetics, February 1, 2008; 178(2): 947 - 956. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Celotto, A. C. Frank, J. L. Seigle, and M. J. Palladino Drosophila Model of Human Inherited Triosephosphate Isomerase Deficiency Glycolytic Enzymopathy Genetics, November 1, 2006; 174(3): 1237 - 1246. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ASPET Journals | Pharmacological Reviews | Drug Metabolism and Disposition |
| Molecular Interventions | Molecular Pharmacology | J Pharmacology and Exp Therapeutics |